Edition:
India

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

7.56USD
1:30am IST
Change (% chg)

$0.47 (+6.63%)
Prev Close
$7.09
Open
$7.09
Day's High
$7.74
Day's Low
$7.09
Volume
64,384
Avg. Vol
151,484
52-wk High
$23.38
52-wk Low
$2.05

Latest Key Developments (Source: Significant Developments)

Biomerica Announces Retirement Of Chief Financial Officer, Hiring Of New CFO And Appointment Of New Member To The Board Of Directors
Monday, 31 Aug 2020 

Aug 31 (Reuters) - Biomerica Inc ::BIOMERICA ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER (CFO), HIRING OF NEW CFO AND APPOINTMENT OF NEW MEMBER TO THE BOARD OF DIRECTORS.BIOMERICA INC - RETIREMENT OF JANET MOORE, COMPANY'S CHIEF FINANCIAL OFFICER.BIOMERICA INC - MOORE WILL REMAIN AN EMPLOYEE OF COMPANY DURING A TRANSITION PERIOD.BIOMERICA INC - ELECTED CATHY COSTE AS A NEW INDEPENDENT MEMBER OF BOARD.BIOMERICA INC - MOORE WILL ALSO BE LEAVING BOARD.BIOMERICA INC - APPOINTMENT OF STEVE SLOAN AS COMPANY'S NEW CFO, EFFECTIVE SEPTEMBER 3, 2020.BIOMERICA INC - MOST RECENTLY, SLOAN SPENT TEN YEARS WITH MEDICAL DEVICE MAKER, MEDTRONIC.  Full Article

Biomerica Inc Files For Common Stock Shelf Of Up To $90 Mln
Wednesday, 22 Jul 2020 

July 21 (Reuters) - Biomerica Inc ::BIOMERICA INC SAYS MAY OFFER AND SELL COMMON STOCK SHELF OF UP TO $90 MILLION - SEC FILING.BIOMERICA INC SAYS IN ADDITION, OFFERING OF UP TO 571,429 SHARES OF COMMON STOCK BY SELLING STOCKHOLDER.  Full Article

Biomerica Announces Updates For H. Pylori Clinical Studies
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Biomerica Inc ::BIOMERICA ANNOUNCES UPDATES FOR H. PYLORI CLINICAL STUDIES.BIOMERICA - BASED ON RECENT DISCUSSIONS WITH FDA, CO NEEDS LESS THAN 40 CLINICAL TRIAL PATIENT SAMPLES IN ADDITION TO 210 SAMPLES ALREADY COLLECTED.BIOMERICA - FINAL CLINICAL PATIENT SAMPLES EXPECTED TO BE COLLECTED OVER NEXT FEW MONTHS, AFTER WHICH CO TO COMPLETE REMAINING STUDIES, PREPARE FDA SUBMISSION.  Full Article

Biomerica Reports Q2 Loss Per Share Of $0.05
Tuesday, 15 Jan 2019 

Jan 15 (Reuters) - Biomerica Inc ::BIOMERICA ANNOUNCES SECOND QUARTER FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.05.Q2 SALES $1.501 MILLION VERSUS $1.614 MILLION.  Full Article

Medline And Biomerica Sign Agreement For Distribution Of Biomerica's Colorectal Screening Test
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Biomerica Inc ::MEDLINE AND BIOMERICA SIGN AGREEMENT FOR DISTRIBUTION OF BIOMERICA’S COLORECTAL SCREENING TEST TO HELP IDENTIFY AN EARLY WARNING SIGN OF COLORECTAL CANCER.BIOMERICA INC - 3-YEAR AGREEMENT WITH MEDLINE INDUSTRIES FOR DISTRIBUTION OF EZ DETECT COLORECTAL DISEASE SCREENING TEST.  Full Article

BRIEF-Biomerica Files For FDA Emergency Use Authorization Of Unique Laboratory Antibody Test For Covid-19

* BIOMERICA FILES FOR FDA EMERGENCY USE AUTHORIZATION (EUA) OF ITS UNIQUE LABORATORY ANTIBODY TEST FOR COVID-19